Single‐center determination of reference factor II and factor X activity level values for the monitoring of vitamin K antagonist therapy
Stéphanie Desage(Université Claude Bernard Lyon 1), Yohann Jourdy(Hospices Civils de Lyon), Christophe Nougier(Hospices Civils de Lyon), Sandra Le Quellec(Hospices Civils de Lyon), Claude Négrier(Université Claude Bernard Lyon 1), Emilie Jousselme(Hospices Civils de Lyon)
Cited by 2
Related Papers
Novel manifestations of immune dysregulation and granule defects in gray platelet syndrome
|Blood|2020|60
Reccurrent F8 Intronic Deletion Found in Mild Hemophilia A Causes Alu Exonization
|The American Journal of Human Genetics|2018|29
Splicing analysis of 26 <i>F8</i> nucleotide variations using a minigene assay
|Haemophilia|2019|17
Severe hemophilia A caused by an unbalanced chromosomal rearrangement identified using nanopore sequencing
|Journal of Thrombosis and Haemostasis|2019|15